|
|
|
|
|
Natraceutical closes 2009 with a negative result of € 43.99 M, attributable to the accounting impact of the Naturex operation
(610,44 Kb)
|
|
|
|
|
|
Naturex, the French multinational corporation in which Natraceutical holds a 35% stake, discloses their 2009 turnover.
(191,96 Kb)
|
|
|
|
|
|
|
Document presented on October 15th 2009 by the chairmans of Natraceutical and Naturex, at the Madrid Stock Exchange
(5.117,58 Kb)
|
|
|
|
|
|
Forté Pharma obtains the authorisation to develop and market medicines in Europe.
(219,41 Kb)
|
|
|
|
|
|
Natraceutical Group issue their 1st half results.
(478,92 Kb)
|
|
|
|
